University of Zurich: Lung Diseases, Obstructive trials
The registry lists 26 Lung Diseases, Obstructive studies with University of Zurich as lead sponsor. 0 are open to participants now and 0 have results posted.
Phase 2 1Phase 3 2Phase 4 13No phase 10(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Exercise Performance on Ambient Air vs. Low-Flow Oxygen Therapy With Chronic Lung DiseasesCompletedNCT06385301Not applicable
- Holistic Wellbeing in COPD: Communication About Sexuality (COSY)CompletedNCT05696730Not applicable
- Visa-versa! Breaking Instead of Pushing the Pedals-BCompletedNCT05185856Not applicable
- Effect of Acetazolamide on Right Heart Function at Rest in Lowlanders With COPD Traveling to High AltitudeStatus unknownNCT04915365Phase 3
- Acetazolamide to Prevent Impending Altitude-illness in Patients With COPDStatus unknownNCT04913389Phase 3
- Early Signs of Altitude Illness in Patients With COPDCompletedNCT03957759
- Effects of HFOT on Exercise Performance in Patients With COPD. A Randomized, Controlled Trial.CompletedNCT03955770Phase 4
- Home-based Exercise Training for COPD Patients (HOMEX-2)CompletedNCT03654092Not applicable
- Effect of Acetazolamide on Lung Water Content by Ultrasound in Patients With Respiratory Disease at AltitudeCompletedNCT03540901Phase 4
- Home-based Exercise Training for COPD PatientsCompletedNCT03461887Not applicable
- Effect of Short-term Oxygen During CPET in COPDCompletedNCT03196089Phase 2
- Effect of Acetazolamide on Sleep Related Breathing Disturbances in Patients With Respiratory Disease at AltitudeCompletedNCT03177850Phase 4
- Effect of Acetazolamide on Exercise Performance in Patients With Respiratory Disease at AltitudeCompletedNCT03177837Phase 4
- Effect of Acetazolamide on Postural Control in Patients With Respiratory Disease at AltitudeCompletedNCT03177811Phase 4
- Effect of Acetazolamide on Right Ventricular Function at Rest in Patients With Respiratory Disease at AltitudeCompletedNCT03173508Phase 4
- Effect of Acetazolamide on Right Ventricular Function During Exercise in Patients With Respiratory Disease at AltitudeCompletedNCT03167034Phase 4
- Effect of Acetazolamide on Cognition in Patients With Respiratory Disease at AltitudeCompletedNCT03165890Phase 4
- Effect Of Acetazolamide On Altitude Related Illness In Patients With Respiratory DiseaseCompletedNCT03156231Phase 4
- Effect of Dexamethasone on Sleep Related Breathing Disturbances in Patients With COPD at AltitudeCompletedNCT02450994Phase 4
- Altitude Related Illness In Patients With Respiratory DiseaseCompletedNCT02450968Phase 4
- Is COPD a Risk Factor for Cardiovascular Disease?CompletedNCT02162095
- Patients With Chronic Obstructive Pulmonary Disease at Altitude - Effect of Nocturnal Oxygen on Breathing and SleepCompletedNCT02150590Phase 4
- Patients With Chronic Obstructive Pulmonary Disease at Altitude - Effect of Nocturnal Oxygen on Exercise PerformanceCompletedNCT02143609Phase 4
- Nocturnal Breathing and Sleep in Patients With Chronic Obstructive Pulmonary Disease Staying at AltitudeCompletedNCT01870830Not applicable
- Phenotypes and Vascular Damage in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01527773
- Mechanisms of Vascular Damage in Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT01020344Not applicable